Candesic Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Consulting
Founded:2002
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • Candesic's estimated annual revenue is currently $9.7M per year.
  • Candesic's estimated revenue per employee is $167,586

Employee Data

  • Candesic has 58 Employees.
  • Candesic grew their employee count by 35% last year.
  • Candesic currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A295N/AN/A-N/A
#2
N/A100N/AN/A-N/A
#3
N/A19412%N/A-N/A
#4
N/A7318%N/A-N/A
#5
$11.5M6821%N/A-N/A
#6
N/A868%N/A-N/A
#7
N/A100N/AN/A-N/A
#8
N/A5746%N/A-N/A
#9
N/A718%N/A-N/A
#10
N/A280N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Candesic provides management consultancy and commercial due diligence services to corporates, private equity and other financial investors, and public sector organisations like the NHS. Our main practices are healthcare and social care, aerospace, defence & security. Candesic was founded in 2002 by Dr Leonid Shapiro and Marc Kitten. The firm is headquartered in London, United Kingdom with additional offices in France, Spain, Italy and India. Commercial Due Diligence (Recent successful Transactions) Acquisition of SERB Pharmaceuticals, valued at 250m according to Mergermarket, by Charterhouse Minority investment in Lucid Group by LDC Acquisition of Carling Group by LDC-owned Fishawack Acquisition of Envision Pharma by Ardian and GHO Capital Acquisition of Priory and Partnerships in Care by BC Partners £320m Acquisition of Orolia by Eurazeo for 100m (public source) Reverse acquisition of Mediclinic by Al Noor for £7.4bn Investment in CEVA Santé Animale by CHD Investments valuing the company over 1.5bn Acquisition of Medical Imaging Partnership by Apposite Capital Metric Capital: investment in Proton Beam Therapy technology Historical transactions AllianceBoots: completed CDD for largest European LBO to date at £12bn Acquisition of Phadia by Cinven for 1.2bn (later sold to Thermo Fisher Scientific for £2.2bn) VCDD Swanton Care: provider of residential care specialised in learning disabilities and Autism Cambian: leading Mental Health provider for patients with Learning Disabilities and Acquired Brain Injuries Danshell: refinancing Strategy Caring Home Group, HC One, HCP REIT, Monarch Alternative Capital: commercial analysis of care homes site Somed: building a private hospital chain in Morocco Bupa: dental market review and strategic options for growth, led to the creation of a leading chain in the UK Schoen Klinik: spanish hospital market workshop GenesisCare: commercial integration of IMO, a Spanish radiotherapy chain

keywords:N/A

58

Number of Employees

$9.7M

Revenue (est)

1

Current Jobs

35%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Candesic News

09/07/2019 - Candesic, CIL, Deloitte and Knight Frank win HealthInvestor Awards

The winners, who were initially short-listed in February, included Candesic, CIL, Deloitte and Knight Frank, who were recognised by clients in ...

09/08/2019 - Shortlists revealed for North West Dealmakers Awards 2019

... issue share to Waterland (Shoosmiths, Clearwater International, Addleshaw Goddard, Deloitte, PwC, Candesic, GK Strategy, Baldwins)

07/01/2019 - How technology is helping the NHS get an upgrade

... all of which have seen their waiting time plummet to an average of four minutes, according to Candesic, an independent consulting firm.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A5812%N/A-N/A
#2
$8.4M58N/AN/A5/5N/A
#3
$8.4M5814%N/A-N/A
#4
$14.7M5835%N/A-N/A
#5
$14.1M5826%N/A-N/A